Patent · US Active

System and apparatus for determining the left-ventricular ejection time TLVE of a heart of a subject

US7904141B2 · kind B2 · utility

5Cited by
59References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 22, 2006
Grant dateMar 8, 2011
Priority date
Expiry dateOct 8, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B5/7239
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

In order to reliably determine the left-ventricular ejection time TLVE of a heart of a subject, at least two different measuring methods are employed. This includes in any case the derivation of a first waveform related to thoracic electrical bioimpedance or bioadmittance. A second waveform can be determined by using pulse oximetry, Doppler velocimetry, measurement of arterial blood pressure and measurement of peripheral electrical bioimpedance or bioadmittance. Depending on signal quality, the results obtained by each method are weighted and then averaged. The weighted average for left-ventricular ejection time is used as an input variable for cardiovascular monitoring methods, which determine objective measurements of cardiovascular function and performance. Such measurements include, but are not limited to, left ventricular ejection fraction, stroke volume, cardiac output, systolic time ratio, and indices of ventricular contractility.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.